XOMA Corp 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th XOMAO 深 滬
等待開盤 10-28 09:30:00 美东时间
25.44
-0.090
-0.35%
華盛通- 最 高25.50
- 今 開25.4803
- 成交量 2206股
- 最 低 25.40
- 昨 收 25.53
- 總市值 4070.40万
- 52周最高 25.55
- 市盈率 靜 --
- 換手率 0.14%
- 52周最低 22.2731
- 委 比 25.00%
- 總股本 160.00万
- 歷史最高 25.50
- 量 比 0.76
- 振 幅 0.39%
- 歷史最低 14.5932
- 每 手 1
- 風險率 0.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Mural Oncology Shareholders Approve Takeover Of XOMA Royalty's XRA 5 Unit
Mural Oncology plc (NASDAQ:MURA) ("Mural") today announced that its shareholders have voted to approve the previously announced proposed acquisition of Mural by XRA 5 Corp. ("Sub"), a wholly owned subsidiary of XOMA
10-25 04:27
XOMA and LAVA Therapeutics Announce Amendment To Purchase Agreement; LAVA Shareholders Who Tender Their Shares Will Now Receive An Initial Cash Amount Per Share Of $1.04; Amendment To Agreement With LAVA Includes Updated CVR Terms For Tender Offer
- Amendment includes finalized cash amount and updated CVR terms for tender offer- LAVA announces new date for extraordinary general meeting of shareholdersEMERYVILLE, Calif. and UTRECHT, The Netherlands and
10-17 23:48
ESSA Announces Completion of Arrangement with XenoTherapeutics
SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada, Oct. 9, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") today announced the completion of XenoTherap...
10-09 19:00
ESSA Securityholders Approve Acquisition by XenoTherapeutics
SOUTH SAN FRANCISCO, USA and VANCOUVER, Canada, Oct. 6, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") is pleased to announce that its Securityholders (as defi...
10-07 05:14
Xoma Announces $125 Million Sales Agreements
An update from Xoma ( ($XOMA) ) is now available. On October 3, 2025, XOMA Roya...
10-04 05:50
LAVA Therapeutics Extends Tender Offer Deadline
The latest announcement is out from LAVA Therapeutics ( ($LVTX) ). On October 2...
10-03 05:30
XOMA Royalty And LAVA Therapeutics Announced The Extension Of The Expiration Of The Tender Offer To Purchase All Outstanding Shares Of Common Shares Of LAVA
EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation ("XOMA Royalty") (NASDAQ:XOMA) and LAVA Therapeutics N.V. ("LAVA") (NASDAQ:LVTX) today
10-03 04:47
ESSA Pharma cuts shareholder payout in revised Xeno deal
ESSA Pharma (NASDAQ:EPIX) fell above 18% premarket on Wednesday after the company revised terms of its merger with biotech firm XenoTherapeutics, lowering expected shareholder payout due to potential ...
09-24 18:35
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.14 per CVR under revised terms Further Adjourns Special Meeting ...
09-24 18:00
Xoma Completes Acquisition of HilleVax
The latest announcement is out from Xoma ( ($XOMA) ). XOMA Royalty Corporation,...
09-24 05:28
